A one-day hybrid conference (offering both in-person and virtual attendance options) exploring the latest advances in haematological malignancies. It will bring together leading experts from across Europe and the USA to discuss cutting-edge developments in blood cancer diagnostics, care and research.

The programme features critical updates on disease classification, targeted therapeutics, and advanced diagnostics including new in situ diagnostic tools and molecular testing.

There will be a dedicated poster session that includes digital and up to 10 printed submissions. This unique forum is open to hematopathologists, clinical haematologists, CNS nurses, researchers and laypeople.